N Engl J Med 2020 Dec 10
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
Related Questions
Current guidelines do not support its use, but the EMPACTA trial suggests it may be effective in a subpopulation of patients.
New comment by at Northwestern Medical Group ( January 20, 2021)
I completely agree, and I anticipate there will be more on this topic soon! One thing to add - in REMAP-CAP and EMPACTA, a large number of patients were also on glucocorticoid...